Legionnaires' disease(redirected from Legionnaires disease)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
A type of pneumonia usually caused by infection with the bacterium Legionella pneumophila, but occasionally with a related species (such as L. micdadei or L. dumoffii). The disease was first observed in an epidemic among those attending an American Legion convention in Philadelphia, Pennsylvania, in 1976. The initial symptoms are headache, fever, muscle aches, and a generalized feeling of discomfort. The fever rises rapidly, reaching 102–105°F (32–41°C), and is usually accompanied by cough, shortness of breath, and chest pains. Abdominal pain and diarrhea are often present. The mortality rate can be as high as 15% in untreated or improperly diagnosed cases. Erythromycin, new-generation fluroquinolones, and rifampicin are considered highly effective medications, whereas the penicillins and cephalosporins are ineffective.
While epidemics of Legionnaires' disease (also referred to as legionellosis) can often be traced to a common source (cooling tower, potable water, or hot tub), most cases seem to occur sporadically. It is estimated that Legionella spp. account for approximately 4% of all community- and hospital-acquired pneumonia. Legionnaires' disease is most fequently associated with persons of impaired immune status. Legionella bacteria are commonly found in fresh water and moist soils worldwide and are often spread to humans through inhalation of aerosols containing the bacteria. Legionnaires' disease is not a communicable disease, indicating that human infection is not part of the survival strategy of these bacteria. Therefore, the legionellae are considered opportunistic pathogens of humans. It is technology (air conditioning) and the ability to extend life through medical advances (such as transplantation and treatments for terminal diseases) that have brought these bacteria into proximity with a susceptible population.
For most humans exposed to L. pneumophila, infection is asymptomatic or short-lived. This is attributed to a potent cellular immune response in healthy individuals. Recovery from Legionnaires' disease often affords immunity against future infection. However, no vaccine exists at the present time. See Medical bacteriology, Pneumonia